Valuation : ORPEA

Market Cap 200.65Cr 232.88Cr 189.99Cr 172.21Cr 323.07Cr 22TCr 324.71Cr 2.26TCr 867.72Cr 11TCr 874.61Cr 855.42Cr 36TCr P/E 2026 *
-15.6x
P/E 2027 * -33.4x
Enterprise Value 758.03Cr 879.8Cr 717.75Cr 650.57Cr 1.22TCr 84TCr 1.23TCr 8.52TCr 3.28TCr 43TCr 3.3TCr 3.23TCr 1,35100Cr EV / Sales 2026 *
1.23x
EV / Sales 2027 * 1.18x
Free-Float
71.92%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 01/07/2022
Compliance Officer - -
Chief Tech/Sci/R&D Officer - 10/10/2022
Director TitleAgeSince
Director/Board Member 57 28/07/2022
Director/Board Member 69 -
Director/Board Member 51 22/12/2023
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 232.88Cr
-0.20%+2.67%+94.63%+231.37% 351.55Cr
-0.49%+3.14%+62.95%+209.69% 289.89Cr
-0.79%-2.34%+3.99%-99.11% 232.88Cr
-0.65%+4.86%+51.71%+424.14% 187.21Cr
-0.45%-4.07%+9.99%+75.47% 158.33Cr
-1.10%-0.66%-43.55%+76.86% 98Cr
-4.47%-8.84% - - 69Cr
+0.37%-8.40%+7.70%+59.90% 67Cr
+0.29%-2.29%+72.88%+135.99% 33Cr
Average -0.75%-1.61%+32.54%+139.29% 165.28Cr
Weighted average by Cap. -0.56%+0.24%+44.00%+159.68%

Financials

2026 *2027 *
Net sales 615.07Cr 713.86Cr 582.39Cr 527.87Cr 990.32Cr 68TCr 995.34Cr 6.92TCr 2.66TCr 35TCr 2.68TCr 2.62TCr 1,09600Cr 637.69Cr 740.12Cr 603.81Cr 547.29Cr 1.03TCr 71TCr 1.03TCr 7.17TCr 2.76TCr 36TCr 2.78TCr 2.72TCr 1,13700Cr
Net income -13Cr -15Cr -12Cr -11Cr -21Cr -1.45TCr -21Cr -147.32Cr -57Cr -738.99Cr -57Cr -56Cr -2.34TCr -5.79Cr -6.72Cr -5.48Cr -4.97Cr -9.32Cr -641.94Cr -9.37Cr -65Cr -25Cr -326.59Cr -25Cr -25Cr -1.03TCr
Net Debt 557.38Cr 646.91Cr 527.76Cr 478.37Cr 897.44Cr 62TCr 901.99Cr 6.27TCr 2.41TCr 31TCr 2.43TCr 2.38TCr 99TCr 549.09Cr 637.3Cr 519.92Cr 471.26Cr 884.1Cr 61TCr 888.58Cr 6.18TCr 2.37TCr 31TCr 2.39TCr 2.34TCr 98TCr
Logo ORPEA
EMEIS is the European leader in global dependency care. The group operates retirement homes, follow-up care clinics, and psychiatric clinics. At the end of 2025, EMEIS has a network of 1,044 establishments (91,995 beds) located in particular in France (360 facilities; 33,402 beds), Northern Europe (383; 27,340 beds), Central Europe (137; 12,667 beds), Southern Europe and Latin America (121; 14,275 beds). As of December 31st , 2024, the estimated value of the real estate portfolio was EUR 5.6 billion. Net sales are distributed geographically as follows: France (41%), Northern Europe (30.2%), Central Europe (16.7%), Southern Europe and Latin America (8%) and other (4.1%).
Employees
-
Trader
Investor
Global
Quality
ESG MSCI
-
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!